| - | ||||||||||||||||||||||||||||
. ; (0): .
| ||||||||||||||||||||||||||||
| How to Cite this Article |
| Pubmed Style Joshua JM, D SK, Vijayan M. Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. Natl J Physiol Pharm Pharmacol. Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 Web Style Joshua JM, D SK, Vijayan M. Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. https://www.njppp.com/?mno=271913 [Access: March 11, 2025]. doi:10.5455/njppp.2018.8.0724705082017 AMA (American Medical Association) Style Joshua JM, D SK, Vijayan M. Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. Natl J Physiol Pharm Pharmacol. Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 Vancouver/ICMJE Style Joshua JM, D SK, Vijayan M. Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. Natl J Physiol Pharm Pharmacol, [cited March 11, 2025]; Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 Harvard Style Joshua, J. M., D, . S. K. & Vijayan, . M. (2018) Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. Natl J Physiol Pharm Pharmacol, Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 Turabian Style Joshua, Julie Mariam, Salima K D, and Meenu Vijayan. 2018. Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. National Journal of Physiology, Pharmacy and Pharmacology, Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 Chicago Style Joshua, Julie Mariam, Salima K D, and Meenu Vijayan. "Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report." National Journal of Physiology, Pharmacy and Pharmacology Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 MLA (The Modern Language Association) Style Joshua, Julie Mariam, Salima K D, and Meenu Vijayan. "Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report." National Journal of Physiology, Pharmacy and Pharmacology Online First: 07 Sep, 2017. Web. 11 Mar 2025 doi:10.5455/njppp.2018.8.0724705082017 APA (American Psychological Association) Style Joshua, J. M., D, . S. K. & Vijayan, . M. (2018) Crizotinib, an effective agent in ROS1-rearranged adenocarcinoma of lungs: A case report. National Journal of Physiology, Pharmacy and Pharmacology, Online First: 07 Sep, 2017. doi:10.5455/njppp.2018.8.0724705082017 |
